연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1357. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.
Kim S1, Kim TM, Kim DW, Go H, Keam B, Lee SH, Ku JL, Chung DH, Heo DS.
J Thorac Oncol. 2013 Apr;8(4):415-22. doi: 10.1097/JTO.0b013e318283dcc0.
Link
1356. Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer.
Keam B1, Kim DW, Park JH, Lee JO, Kim TM, Lee SH, Chung DH, Heo DS.
Int J Clin Oncol. 2013 Aug 6. [Epub ahead of print]
Link
1355. Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm.
Go H1, Kim DW, Kim D, Keam B, Kim TM, Lee SH, Heo DS, Bang YJ, Chung DH.
J Thorac Oncol. 2013 Nov;8(11):1445-50. doi: 10.1097/JTO.0b013e3182a4dd6e.
Link
1354. How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution.
Keam B1, Kim DW, Park JH, Lee JO, Kim TM, Lee SH, Chung DH, Heo DS.
Cancer Res Treat. 2013 Sep;45(3):178-85. doi: 10.4143/crt.2013.45.3.178. Epub 2013 Sep 30.
Link
1353. Quantitative thoracic CT techniques in adults: can they be applied in the pediatric population?
Yoon SH1, Goo JM, Goo HW.
Pediatr Radiol. 2013 Mar;43(3):308-14. doi: 10.1007/s00247-012-2467-2. Epub 2013 Feb 16.
Link
1352. Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines.
Ku JL1, Park SC, Kim KH, Jeon YK, Kim SH, Shin YK, Noh DY, Im SA, Bang YJ, Han W, Kim WH, Park JG.
Int J Oncol. 2013 Dec;43(6):2073-81. doi: 10.3892/ijo.2013.2144. Epub 2013 Oct 18.
Link
1351. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.
Kim S1, Kim TM, Kim DW, Go H, Keam B, Lee SH, Ku JL, Chung DH, Heo DS.
J Thorac Oncol. 2013 Apr;8(4):415-22. doi: 10.1097/JTO.0b013e318283dcc0.
Link
1350. Clinical characteristics of pediatric thalassemia in Korea: a single institute experience.
Hong CR1, Kang HJ, Lee JW, Kim H, Kim NH, Park KD, Park JD, Seong MW, Park SS, Shin HY, Ahn HS.
J Korean Med Sci. 2013 Nov;28(11):1645-9. doi: 10.3346/jkms.2013.28.11.1645. Epub 2013 Oct 31.
Link
1349. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Kim H1, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS.
Childs Nerv Syst. 2013 Oct;29(10):1851-8. doi: 10.1007/s00381-013-2163-z. Epub 2013 Jun 9.
Link
1348. Pharmacogenetic study of deferasirox, an iron chelating agent.
Lee JW1, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS.
PLoS One. 2013 May 30;8(5):e64114. doi: 10.1371/journal.pone.0064114. Print 2013.
Link